EP 2306839 A4 20110817 - GACYCLIDINE FORMULATIONS
Title (en)
GACYCLIDINE FORMULATIONS
Title (de)
GACYCLIDINFORMULIERUNGEN
Title (fr)
FORMULATIONS DE GACYCLIDINE
Publication
Application
Priority
- US 2009047801 W 20090618
- US 7413408 P 20080619
Abstract (en)
[origin: WO2009155421A1] Colloidal suspensions comprising gacyclidine and squalene. Squalene binds gacyclidine much more tightly than other drug carriers, such as polylactic glycolic acid. Including squalene in the particulate pahse sequesters gacyclidine and provides superior stability at room or body temperature.
IPC 8 full level
A61K 31/453 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/51 (2006.01); A61K 31/13 (2006.01); A61K 31/135 (2006.01); A61K 31/445 (2006.01); A61K 31/451 (2006.01); A61P 25/00 (2006.01)
CPC (source: EP)
A61K 9/0024 (2013.01); A61K 9/0046 (2013.01); A61K 9/0048 (2013.01); A61K 9/0097 (2013.01); A61K 9/1075 (2013.01); A61K 31/137 (2013.01); A61K 31/4535 (2013.01); A61P 25/00 (2017.12)
Citation (search report)
- [X] CHUNG H ET AL: "Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 71, no. 3, 28 April 2001 (2001-04-28), pages 339 - 350, XP004234531, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(00)00363-1
- See references of WO 2009155421A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2009155421 A1 20091223; EP 2306839 A1 20110413; EP 2306839 A4 20110817
DOCDB simple family (application)
US 2009047801 W 20090618; EP 09767730 A 20090618